Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
SAGE documentation
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (355)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1150)
Topics
Evidence to recommendation table (2)
GRADE table (2)
Meeting report (9)
Position paper (16)
SAGE background document (4)
Regions
Global (1)
Diseases
COVID-19 (34)
Cholera (5)
Dengue (13)
Diphtheria (4)
Ebola (6)
Haemophilus influenzae type B (4)
Hepatitis A (11)
Hepatitis B (4)
Hepatitis E (2)
Herpes zoster (2)
Human papillomavirus (HPV) (18)
Influenza (17)
Japanese encephalitis (10)
Malaria (13)
Measles (14)
Meningococcal disease (7)
Mpox (7)
Mumps (2)
Pertussis (4)
Pneumococcal disease (12)
Poliomyelitis (20)
Rabies (5)
Rotavirus (1)
RSV (Respiratory syncytial virus) (4)
Rubella (8)
Smallpox (1)
Tetanus (2)
Tick-borne encephalitis (1)
Tuberculosis (9)
Typhoid (8)
Varicella (3)
Yellow fever (3)
Show more
Methodological quality (AMSTAR 2)
Not applicable (1)
Publication date
2026 (1)
2024 (2)
2023 (4)
2022 (18)
2021 (6)
2020 (3)
Available to download in languages
en (32)
34 results found
2022
∙
SAGE
Annexes to the interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
2022
∙
SAGE
Background document on the Valneva VLA2001 vaccine against COVID-19
2022
∙
SAGE
Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
2022
∙
SAGE
Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
2022
∙
SAGE
Interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
2021
∙
SAGE
Meeting of Strategic Advisory Group of Experts on Immunization, October 2021: conclusions and recommendations
2021
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, 22–24 March 2021: conclusions and recommendations
2021
∙
SAGE
Background document on the Bharat Biotech BBV152 COVAXIN® (COVID-19) vaccine
2021
∙
SAGE
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
2021
∙
SAGE
Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register